Skip to main content

BMS IM027-068 IPF A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Bristol-Myers Squibb Company

Start Date

November 14, 2023

End Date

June 14, 2028
 

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Bristol-Myers Squibb Company

Start Date

November 14, 2023

End Date

June 14, 2028